Christopher L. Jordan
Conseiller Juridique Général chez CHIMERIX, INC.
Postes actifs de Christopher L. Jordan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHIMERIX, INC. | Conseiller Juridique Général | 08/08/2022 | - |
Historique de carrière de Christopher L. Jordan
Anciens postes connus de Christopher L. Jordan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ENDOCYTE, INC. | Conseiller Juridique Général | - | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| NOVARTIS AG | Conseiller Juridique Général | - | - |
Formation de Christopher L. Jordan
| George Washington University | Graduate Degree |
| Purdue University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Suisse | 2 |
Opérationnelle
| General Counsel | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Bourse
- Insiders
- Christopher L. Jordan
- Expérience
